The ICRP (lCRP, 1991) has specified the following values of the tissue weighting factors together with some information concerning the "Remainder."
For purposes of calculation, the remainder is composed of the following additional tissues and organs: adrenals, brain, upper large intestine, small intestine, kidney, muscle, pancreas, spleen, thymus and uterus.
The list includes organs which are likely to be selectively irradiated. Some organs in the list are known to be susceptible to cancer induction. If other tissues and organs subsequently become identified as having a significant risk of induced cancer, they will then be included either with a specific WT or in this additional list constituting the remainder. The latter may also include other tissues or organs selectively irradiated.
In those exceptional cases in which a single one of the remainder tissues or organs receives an equivalent dose in excess of the highest dose in any of the twelve organs for which a weighting factor is specified, a weighting factor of 0.025 should be applied to that tissue or organ and a weighting factor of 0.025 to the average dose in the rest of the remainder as defined above.
The WT'S previously specified by the ICRP (lCRP, 1977; see also Appendix A in ICRU Report 43 (lCRU, 1988) ) have been used in former determinations of dose equivalents from external radiation sources which led to the definitions of operational quantities. A joint ICRU-ICRP Report Committee is currently examining the influence on those quantities of the new W T' S as well as their pertinence to the new limitation quantities defined in the 1990 Recommendations of the ICRP (lCRP, 1991) .
